As evidence has mounted that new diabetes and weight loss drugs can provide a variety of health benefits, the FDA has ...
GLP-1 class of weight loss and diabetes drugs are linked to previously unrecognized health risks and benefits, according to a ...
Tirzepatide, the main ingredient in Mounjaro and Zepbound, is no longer in shortage, according to the U.S. Food and Drug Administration. Compounded copycat drugs containing tirzepatide, many sold ...
Hundreds of people have been hospitalised by the side effects of weight-loss drugs. There were 118 in November alone, ...
The FDA approved Zepbound (tirzepatide) as the first prescription ... in the body that stimulate insulin secretion and sensitivity after a person eats. The drug regulates the body’s blood ...